Huntsman Cancer Institute — Salt Lake City, Utah

Public research footprint of Huntsman Cancer Institute, compiled from the ClinicalTrials.gov public registry.

1,447

Registered studies

548

Active

258

Recruiting now

637

Completed

219

Stopped or withdrawn

Most-studied conditions

NSCLC (Advanced Non-small Cell Lung Cancer) · Breast Cancer · Glioblastoma Multiforme (GBM) · Endometrial Dedifferentiated Carcinoma

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Huntsman Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.